Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodes

Annals of Surgical Oncology

Volumn 12, Issue 1, 2005, Pages 3-5

  Eggermont, Alexander M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; HUMAN; LYMPH NODE; MELANOMA; METASTASIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; ULTRASOUND;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 16844387337     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2005.09.911     Document Type: Editorial

References (15)

1. Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol (in press)
2. C Garbe A Paul H Kohler-Spath 2003 Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 520 9
3. AY Kanter CH van Eijck AN van Geel 1999 Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer Br J Surg 86 1459 62
4. K Sato K Tamaki H Tsuda 2004 Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsy Am J Surg 187 679 83
5. EE Deurloo PJ Tanis KG Gilhuijs 2003 Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer Eur J Cancer 39 1068 73
6. CR Rossi S Mocellin B Scagnet 2003 The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients J Surg Oncol 83 80 4
7. R Essner MH Chung R Bleicher E Hsueh L Wanek DL Morton 2002 Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy Ann Surg Oncol 9 754 61
8. N Mozzillo C Caraco MG Chiofalo 2004 Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up Eur J Surg Oncol 30 440 3
9. GW Carlson DR Murray A Hestley CA Staley RH Lyles C Cohen 2003 Sentinel lymph node mapping for thick (>=4-mm) melanoma: should we be doing it? Ann Surg Oncol 10 408 415
10. JF Thompson HM Shaw 2002 The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome? Ann Surg Oncol 9 754 61
11. JM Kirkwood J Manola J Ibrahim V Sondak MS Ernstoff U Rao 2004 A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma Clin Cancer Res 10 1670 7
12. K Wheatley N Ives B Hancock M Gore AMM Eggermont S. Suciu 2003 Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials Cancer Treat Rev 29 241 52
13. AMM Eggermont M. Gore 2002 European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma Semin Oncol 29 382 8
14. LE. Spitler 2002 Adjuvant therapy of melanoma Oncology 16 Suppl 1 S40 8
15. AMM Eggermont U Keilholz A Testori M Cook D Lienard DJ Ruiter 2001 The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer Ann Surg Oncol 8 9 Suppl 38S 40S